Advertisement
Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates
From: A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance
